BUY. Well poised for strong growth RBL BANK. Target Price: Rs 650. Key highlights. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Similar documents
HOLD. Buyback of Old Mutual s stake in K-Life KOTAK MAHINDRA BANK. Target Price: Rs 965

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

BUY. Structural changes in the making CAPITAL FIRST. Target Price: Rs 920. Key drivers

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Hold Target Price: Rs 574

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Change EPS. (Rs) FY

HOLD PVR. Operating matrix healthy; footfalls subdued. Target Price: Rs 1,520. Key highlights

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%)

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190

BUY. IIB-BHAFIN merger a done deal INDUSIND BANK. Target Price: Rs 1,920. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

BUY. Quess likely to be spun-off; stay invested THOMAS COOK (INDIA) Target Price: Rs 320

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY

BUY. GST pressures dealt well HINDUSTAN UNILEVER. Target Price: Rs 1,400. Key drivers (%) FY16 FY17 FY18E FY19E

BUY Target Price: Rs 1,218

HOLD. FY18 off to a good start GODREJ PROPERTIES. Target Price: Rs 486. Q4FY17 key highlights

HOLD. Going aggressive in hair oils DABUR INDIA. Target Price: Rs 325. Key drivers (%) FY17 FY18E FY19E

BUY. Shedding non-core assets TATA POWER. Target Price: Rs 136. Financial summary (Consolidated) Key drivers. Price performance

Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

BUY. FY17 a blip; gradual recovery ahead APOLLO HOSPITALS ENTERPRISE. Target Price: Rs 1,472

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Punjab National Bank

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

NOW ON APP Research at your finger tips

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

HOLD Rating as per Large Cap 12 month investment period

I Direct. nstinct. November 27, 2017

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Financial summary. Year

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

IndusInd Bank (INDBA) 1717

Reliance Capital (RELCAP) 549

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

Buy Rating as per Mid Cap 12months investment period

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

RBL Bank BUY. CMP Target Price `573 `690. Quick take BANK. January 7, year price chart

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

BUY. Multiple margin tailwinds; BUY HINDUSTAN UNILEVER. Target Price: Rs 1,010. Key drivers (%) FY16 FY17E FY18E FY19E

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Bajaj Finance (BAJAF) 5498

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

State Bank of India (SBI)

Fineotex Chemical Ltd

Bank of Baroda (BOB)

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Cummins India Ltd Bloomberg Code: KKC IN

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Bajaj Finserv (BAFINS) 5443

BUY RETAIL EQUITY RESEARCH. HDFC Ltd. NBFC. Better placed among housing finance companies (HFCs) GEOJIT BNP PARIBAS Research

Punjab National Bank

Bajaj Finserv (BAFINS) 4375

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

Federal Bank BUY RETAIL EQUITY RESEARCH

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

BUY Rating as per Largecap 12months investment period

Ahluwalia Contracts (India)

Union Bank of India (UNIBAN)

FY16 FY17 FY18E FY19E

Visaka Industries Ltd

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Simplex Infrastructures

FY17 FY18 FY19E FY20E

Ujjivan Financial Services Ltd Banking/Finance BUY RETAIL EQUITY RESEARCH

Key estimate revision. Financial summary. Year

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Bajaj Finserv (BAFINS) 3130

Repco Home Finance REPCO IN

M&M Financial Services (MMFSL)

Federal Bank Ltd. Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

Ujjivan Financial Services Ltd Banking/Finance. Accumulate RETAIL EQUITY RESEARCH

Bank of Baroda (BANBAR) 156

LIC Housing Finance. Source: Company Data; PL Research

State Bank of India (STABAN) 335

Margin boost through non-core book

Transcription:

4 APR 218 Visit Note BUY Target Price: Rs 65 Well poised for strong growth We met with the senior management of RBL and came back confident on its outlook and execution capabilities. Growth rates to remain healthy with benefits flowing from multi-channel distribution network. NIM to remain intact with granular retail franchise. Some near-term challenges persists like asset quality pain in farm loan book and credit costs linked to demon-impacted MFI loans, which will ease over next few quarters. We expect RBL to scale up materially without any significant teething issues while achieving best in class performance across major parameters. RBL is transitioning from being a wholesale-focused regional player to an agile technology-leader with a diversified portfolio, focus on strategic niche customer segments, and pan-india aspirations. Retain BUY with a TP of Rs 65. CMP : Rs 477 Potential Upside : 36% MARKET DATA No. of Shares : 42 mn Free Float : 1% Market Cap : Rs 2 bn 52-week High / Low : Rs 6 / Rs 443 Avg. Daily vol. (6mth) : 1.3 mn shares Bloomberg Code : RBK IB Equity Promoters Holding : % FII / DII : 38% / 12% Key highlights Credit cost guidance remains intact at 2-2.5% for FY18. GNPAs in the financial inclusion business is expected to be brought down to ~1% (5.2% in Q3FY18) after the accelerated provisions and write-offs in FY19 Loan growth is expected to remain strong at -35% going forward. Credit card business is expected to gain strong traction and will be a high ROA generating business Given the benefit from reduction in cost of funds and gradual change in loan mix in favour of retail, NIM is expected to be maintained ~3.9% Maintain BUY with TP of Rs 65 (3.4x FY2E ABV; upside 36% from CMP): RBL will command a premium to peers given (1) loan growth 3-4x of industry for foreseeable future, (2) ample scope of improving its low cost deposits and fee income, (3) negligible legacy issues, and (4) value accretion from significant rise in retail assets (tie-up with Bajaj Finance/new gen/e-comm players). We value RBL at 3.4x FY2E P/ABV to arrive at TP of Rs 65. At CMP of Rs 477, RBL trades at 2.5x FY2E P/ABV. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY2E PAT (Rs mn) 4,46 6,321 8,646 11,6 EPS (Rs) 12 15 21 28 EPS chg 32. 27.2 36.8 34.2 Book value (Rs) 116 157 175 199 Adj. BV (Rs) 113 151 169 193 PE (x) 4.1 31.5 23.1 17.2 P/ABV (x) 4.2 3.2 2.8 2.5 RoE 12.2 11.6 12.5 14.8 RoA 1. 1.2 1.3 1.3 Net NPA.6 1..8.6 Key drivers Q1 18 Q2 18 Q3 18 YoY Loan growth 4 35 38 NIM 3.5 3.7 3.9 Cost-Income ratio 51. 54.2 54. GNPA ratio 1.5 1.4 1.6 Price performance 14 12 1 BANKEX RBL Bank, CMP as on 27th Mar 218 8 Apr-17 Jul-17 Oct-17 Jan-18 1

Concerns over asset quality of microfinance business abating GNPA ratio in the financial inclusion business seemed to have peaked (5.2% in Q3FY18). RBL has already provided for 35% of the pain portfolio and the balance will be provided for in FY19. Post the accelerated provisioning and write-offs, GNPAs in this business is expected be brought down to ~1% by FY19 end Normalized credit cost in the microfinance business is ~5-7 bps. FY2 onwards the management aims to strengthen this portfolio by creating additional buffers for any unexpected events in the future RBL is not disbursing new microfinance loans in problematic areas but collection process is continuing with a recovery rate of ~25% Exhibit 1: Trend in asset quality GNPA NNPA PCR (RHS) 2. 1.6 1.5 1.4 1.6 1.2 1.2 1.1.9 1. 1.1 1.1 1.1.8.4. Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY16 FY17 FY18 6 5 4 2 1 Management highlighted that 75% of the current microfinance portfolio has been disbursed post Jan'17 with low expected credit cost of ~ bps Overall credit costs guidance maintained at 2-2.5% GNPA ratio in the credit card business stood ~1.1% in Q3FY18 and is better than industry average of 1.5-1.8%. Management highlighted that asset quality of this business is getting better with improving origination quality and credit tested customers of BAF linked credit cards RBL's internally generated agri book stands at Rs 19 bn and has remained stagnant over past two years given the monsoon and political disturbances surrounding the sector. Some challenges may be visible in this book in near term Management is recalibrating its strategy about growing the agri book by doing selective product lending, but will remain watchful over next six months Exhibit 2: Trend in credit cost 4 (bps) 37 32 35 2 1 18 19 16 26 26 Overall credit cost guidance for FY18 was maintained at 2-2.5% Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY16 FY17 FY18 2

Credit card business gaining strong traction Post the launch of co-branded credit card with Bajaj Finance (BAF), RBL is witnessing strong traction in this portfolio. BAF contributes nearly 5% to RBL's credit card base of ~.7 mn cards RBL aims to add nearly 1 mn cards in FY19 and intends to be the 3rd/4th largest card issuer in the country over the next 4-5 years ROA in this business is ~1%. Credit card is an upfront heavy investment business but over the next 3-4 years, this business is expected to generate ROA of 4-5% RBL cross sell like "loan on phone" to a credit card customer will lead to fee income for BAF and should increase substantially as volumes increase Management aims to ramp up BAF-linked credit card business significantly over the next few years and believes it will be a high ROE generating business given that it has limited sourcing costs, provided to existing credit tested customers and completely digital Exhibit 3: RBL has a diversified loan book 1% 8% 6% 4% 2% % C&IB CB BBB Agri DB&FI 14 14 15 14 15 14 14 13 14 13 9 8 8 8 7 7 7 7 6 5 15 17 16 17 17 18 18 2 21 21 24 23 22 21 19 19 19 18 18 18 38 38 39 4 43 43 42 42 41 42 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY16 FY17 FY18 Credit growth guidance maintained at -35% The bank largely follows a cross-sell model in growing the wholesale book and expects this book to grow by ~%. A large part of the growth is driven by the fact that public sector banks have vacated the space and pricing pressure is gradually easing off Management highlighted that RBL has business relations with 4-5% of India s top 1 groups in some form or the other. The bank has stayed away from generic infra loans and largely focused on shorter tenure like 2-3 years rather than 15 year loans in the infra space Management highlighted that RBL has business relations with 4-5% of India s top 1 groups in some form or the other The management highlighted that they are witnessing early signs of private sector capex picking up. Also, they are expecting refinancing opportunities in the next 12-18 months related to resolutions of large stressed accounts The bank has tie-ups with 8 business correspondents for the microfinance and MSME business. Its subsidiary, Swadhaar FinServe originates 4% of the incremental microfinance business and contributes 35% to the portfolio. More so, it contributes a bulk of the MSME business 3

Exhibit 4: Management guides for -35% credit growth in longer run Advances YoY Growth (RHS) 8 (Rs bn) 54 47 47 54 6 39 683 35 32 525 4 397 2 294 212 64 98 144 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY2E 6 5 4 2 1 NIM expected to stay intact Cost of funds has come down for RBL over the past few quarters given reduction in market rates, progressive reduction in deposit rates as well as improvement in CASA ratio (24% in Q3FY18) This in part has aided NIM which has been consistently improving over the past few quarters. Management is hopeful of maintaining NIM at ~3.9% Exhibit 5: Margin (calc) to remain largely resilient at current level 15 12 9 6 3 NIM (RHS) Yields on advances Cost of funds 2.8 2.5 2.7 2.7 3. 3.5 3.5 3.4 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY2E 4.5 4. 3.5 3. 2.5 2. 1.5 4

Financial summary (Standalone) Profit & loss (Rs mn) Y/E March FY17 FY18E FY19E FY2E Interest earned 37,132 45,554 57,641 73,936 Interest expended (24,918) (28,76) (34,963) (45,611) Net interest income 12,213 17,478 22,678 28,325 Non interest income 7,555 1,51 13,744 16,955 Net income 19,768 27,979 36,422 45,28 Operating expenses (1,564) (14,834) (19,26) (23,112) Staff expenses (4,461) (5,713) (7,21) (9,137) Other operating expenses (6,12) (9,12) (11,825) (13,975) Operating profit 9,24 13,146 17,396 22,168 Provisions & contingencies (2,389) (3,569) (4,296) (4,592) Pre-tax profit 6,815 9,577 13,1 17,576 Tax expense (2,354) (3,256) (4,454) (5,976) Profit after tax 4,46 6,321 8,646 11,6 Extraordinary item - - - - Minority interest/associates - - - - Adj. PAT 4,46 6,321 8,646 11,6 Balance sheet (Rs mn) Y/E March FY17 FY18E FY19E FY2E Total assets 486,748 593,421 763,427 971,691 Cash & Balances with RBI 41,936 4,542 46,465 57,486 Investments 134,817 136,428 167,963 23,469 Advances 294,49 397,292 524,855 682,642 Fixed assets 2,587 2,393 2,137 1,812 Other assets 12,917 16,765 22,7 26,282 Total liabilities 486,748 593,42 763,427 971,691 Equity capital 3,752 4,18 4,18 4,18 Preference capital - - - - Reserves & surplus 39,594 61,58 68,981 79,114 Networth 43,346 65,688 73,161 83,294 Borrowings 79,798 87,777 94,96 15,781 Deposits 345,881 418,998 568,832 752,215 Other liabilities & prov. 17,713 2,947 26,465,391 Key ratios Y/E March FY17 FY18E FY19E FY2E Per share data FDEPS (Rs.) 12 15 21 28 BV (Rs.) 116 157 175 199 Adj. BV (Rs.) 113 151 169 193 DPS (Rs.) - 2 2 3 Dividend payout - 12 12 11 Yields & Margins Yield on advances 1.4 1.2 1. 1. Cost of deposit 6.7 6.3 6.2 6.2 Net interest margin 3. 3.5 3.5 3.4 Asset quality Gross NPAs 1.2 1.6 1.3 1.1 Net NPAs.6 1..8.6 Credit cost.8.9.9.7 Provisioning coverage 46.8 4. 42. 45. Capital Tier-I 11.4 16.1 14.7 8.6 CAR 13.7 18.6 17. 1.1 Efficiency ROA 1. 1.2 1.3 1.3 ROE 12.2 11.6 12.5 14.8 Cost to income 53 53 52 51 CASA 22 24 24 24 Effective tax rate 35 34 34 34 Growth Net interest income 49 43 25 Fee income 43 4 31 23 Operating expenses 38 4 28 21 Profit after tax 52 42 37 34 Advances 39 35 32 Deposits 42 21 36 32 Total assets 24 22 29 27 Note: Dividend for FY17 will be reflected in FY18 due to change in reporting method as per schedule 3 5

Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 214 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com. 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associates do not have any material conflict of interest. I/we have not served as director, officer or employee in the subject company. Research Team Sr. No Name Designation E-mail 1 Research Analyst siji.philip@axissecurities.in Research Analyst 2 Research Associate rohit.chawla@axissecurities.in Research Associate 5. ASL or its associates has not received any compensation from the subject company in the past twelve months. ASL or its Research Analysts has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report. 6

DEFINITION OF RATINGS Disclaimer: Ratings Expected absolute returns over 12-18 months BUY More than 1% HOLD Between 1% and -1% SELL Less than -1% Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI INZ161633, ARN No. 6461, CDSL-IN-DP-CDSL-693-213, SEBI-Research Analyst Reg. No. INH 297, SEBI Portfolio Manager Reg. No.- INP654, Main/Dealing off.- Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-47, Tel No. 182188, Reg. off.- Axis House, 8th Floor, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai 4 25.Compliance Officer: Anand Shaha, E-Mail ID: compliance.officer@axisdirect.in,tel No: 22-42671582. 7